Northern Trust’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.49M | Sell |
170,018
-12,095
| -7% | -$205K | ﹤0.01% | 2836 |
|
|
2026
Q1 | $2.9M | Buy |
182,113
+3,288
| +2% | +$71.4K | ﹤0.01% | 2766 |
|
|
2025
Q4 | $4.7M | Sell |
178,825
-22,001
| -11% | -$571K | ﹤0.01% | 2507 |
|
|
2025
Q3 | $4.54M | Buy |
200,826
+410
| +0.2% | +$8.44K | ﹤0.01% | 2558 |
|
|
2025
Q2 | $3.98M | Sell |
200,416
-853
| -0.4% | -$16.6K | ﹤0.01% | 2589 |
|
|
2025
Q1 | $3.4M | Sell |
201,269
-24,093
| -11% | -$410K | ﹤0.01% | 2626 |
|
|
2024
Q4 | $4.16M | Buy |
225,362
+12,291
| +6% | +$240K | ﹤0.01% | 2614 |
|
|
2024
Q3 | $4.63M | Sell |
213,071
-4,460
| -2% | -$99.7K | ﹤0.01% | 2522 |
|
|
2024
Q2 | $4.27M | Sell |
217,531
-3,497
| -2% | -$73K | ﹤0.01% | 2483 |
|
|
2024
Q1 | $4.8M | Sell |
221,028
-10,368
| -4% | -$257K | ﹤0.01% | 2480 |
|
|
2023
Q4 | $6.69M | Buy |
231,396
+7,588
| +3% | +$203K | ﹤0.01% | 2325 |
|
|
2023
Q3 | $5.98M | Buy |
223,808
+466
| +0.2% | +$15.9K | ﹤0.01% | 2335 |
|
|
2023
Q2 | $8.27M | Sell |
223,342
-1,322
| -0.6% | -$46.1K | ﹤0.01% | 2200 |
|
|
2023
Q1 | $7.01M | Sell |
224,664
-1,261
| -0.6% | -$40.6K | ﹤0.01% | 2255 |
|
|
2022
Q4 | $6.73M | Buy |
225,925
+5,656
| +3% | +$202K | ﹤0.01% | 2285 |
|
|
2022
Q3 | $8.4M | Sell |
220,269
-38,244
| -15% | -$1.92M | ﹤0.01% | 2108 |
|
|
2022
Q2 | $14.1M | Buy |
258,513
+38,851
| +18% | +$2.14M | ﹤0.01% | 1773 |
|
|
2022
Q1 | $13.7M | Sell |
219,662
-40,926
| -16% | -$2.69M | ﹤0.01% | 1941 |
|
|
2021
Q4 | $26.2M | Buy |
260,588
+1,134
| +0.4% | +$99.7K | ﹤0.01% | 1579 |
|
|
2021
Q3 | $23.3M | Buy |
259,454
+101,391
| +64% | +$9.22M | ﹤0.01% | 1684 |
|
|
2021
Q2 | $14.6M | Sell |
158,063
-28,199
| -15% | -$2.25M | ﹤0.01% | 2113 |
|
|
2021
Q1 | $18M | Buy |
186,262
+1,163
| +0.6% | +$120K | ﹤0.01% | 1899 |
|
|
2020
Q4 | $9.64M | Buy |
185,099
+35,402
| +24% | +$1.48M | ﹤0.01% | 2266 |
|
|
2020
Q3 | $5.99M | Sell |
149,697
-2,040
| -1% | -$63.9K | ﹤0.01% | 2411 |
|
|
2020
Q2 | $2.43M | Buy |
151,737
+123,253
| +433% | +$1.89M | ﹤0.01% | 2937 |
|
|
2020
Q1 | $306K | Sell |
28,484
-26
| -0.1% | -$362 | ﹤0.01% | 3569 |
|
|
2019
Q4 | $368K | Buy |
28,510
+11,287
| +66% | +$134K | ﹤0.01% | 3633 |
|
|
2019
Q3 | $179K | Buy |
+17,223
| New | +$163K | ﹤0.01% | 3791 |
|
|
2017
Q2 | – | Sell |
-31,248
| Closed | -$342K | – | 4283 |
|
|
2017
Q1 | $342K | Buy |
31,248
+13,738
| +78% | +$162K | ﹤0.01% | 3635 |
|
|
2016
Q4 | $203K | Buy |
+17,510
| New | +$165K | ﹤0.01% | 3762 |
|
Other funds holding FLGT
DC
Northern Trust's FLGT Position: Q2 2026 in Review
Northern Trust reduced its Fulgent Genetics (FLGT) stake by 6.6% in Q2 2026, selling an estimated $205K and leaving 170,018 shares worth $3.49M. The position accounts for ﹤0.01% of the portfolio, ranked #2836.
Northern Trust first reported a position in FLGT in Q4 2016 and has held it in 30 quarters since. The position peaked at $26.2M in Q4 2021. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.
- Northern Trust held 170,018 shares of Fulgent Genetics worth $3.49M as of Q2 2026.
- Northern Trust sold 12,095 Fulgent Genetics shares in Q2 2026, an estimated $205K.
- Fulgent Genetics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2836 holding.
- Northern Trust first reported a position in Fulgent Genetics in Q4 2016 and has held it in 30 quarters since.
- Northern Trust's Fulgent Genetics position peaked at $26.2M in Q4 2021.
- 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.